Impact of CYP2C19 Genotype on Sertraline and Escitalopram Exposure and Antidepressant Switching Rate: A Retrospective Cohort Study of Chinese Han Patients

Documenti analoghi

• Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
  di: Ethan A. Poweleit, et al.
  Pubblicazione: (2024)
• Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
  di: Yoo Jin Jang, et al.
  Pubblicazione: (2024)
• Association of Initial Laxative Strategy With Clinical Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Cohort Study
  di: Bingfu Wang, et al.
  Pubblicazione: (2026)
• Repurposing Sertraline for the Treatment of Colorectal Cancer by Blocking Autophagic Flux and Inhibiting Tumor Proliferation
  di: Leping He, et al.
  Pubblicazione: (2024)
• Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
  di: Danwei Shao, et al.
  Pubblicazione: (2026)